Lundbeck
HLUN-B.CO
#2294
Rank
โ‚น771.97 B
Marketcap
โ‚น778.08
Share price
0.18%
Change (1 day)
19.98%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): โ‚น69.37

According to Lundbeck's latest financial reports the company's current EPS (TTM) is โ‚น72.20. In 2025 the company made an earnings per share (EPS) of โ‚น48.08 an increase over its 2024 EPS that were of โ‚น41.99.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น69.3744.27%
2025โ‚น48.0814.5%
2024โ‚น41.9929.29%
2023โ‚น32.4823.09%
2022โ‚น26.3937.26%
2021โ‚น19.22-84.61%
2020โ‚น124.92-24.61%
2019โ‚น165.69-42.06%
2018โ‚น285.9740.7%
2017โ‚น203.26146.26%
2016โ‚น82.54-120.48%
2015-โ‚น402.923231.32%
2014-โ‚น12.10-115.78%
2013โ‚น76.64-23.36%
2012โ‚น100.00-48.01%
2011โ‚น192.35-9.68%
2010โ‚น212.9813.72%
2009โ‚น187.2824.32%
2008โ‚น150.65-6.05%
2007โ‚น160.3581.77%
2006โ‚น88.21-16.76%
2005โ‚น105.98-17.58%
2004โ‚น128.59